Abbott Laboratories (ABT) Divestments (2015 - 2021)

Abbott Laboratories has disclosed Divestments across 5 years of filings, most recently posting $86.0 million for Q3 2021.

• Divestments for Q3 2021 came in at $86.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $86.0 million (down 10.42% YoY), and the FY2024 annual result was $1.0 million, down 97.5% from the prior year.
• Divestments came in at $86.0 million for Q3 2021 at Abbott Laboratories, up from $10.0 million in the prior quarter.
• In the past five years, Divestments ranged from a high of $1.7 billion in Q1 2017 to a low of -$29.0 million in Q3 2017.
• The 3-year median for Divestments is $48.0 million (2020), against an average of $391.8 million.
• Peak annual rise in Divestments reached 6640.0% in 2017, while the deepest fall reached 6640.0% in 2017.
• Abbott Laboratories' Divestments stood at $600.0 million in 2017, then slumped by 98.33% to $10.0 million in 2020, then surged by 760.0% to $86.0 million in 2021.
• The last three Divestments figures came in at $86.0 million (Q3 2021), $10.0 million (Q4 2020), and $600.0 million (Q4 2017), per Business Quant data.